Medical treatment options for COVID-19

L Delang, J Neyts - European Heart Journal: Acute …, 2020 - journals.sagepub.com
Therapeutic options for coronavirus disease 2019 are desperately needed to respond to the
ongoing severe acute respiratory syndrome coronavirus 2 pandemic. Both antiviral drugs …

Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019

A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …

[PDF][PDF] Therapeutic options for COVID-19: a review

R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - cureus.com
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …

Coronavirus disease 2019 treatment: a review of early and emerging options

EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

Treatment of SARS-CoV-2: How far have we reached?

W Ahsan, S Javed, M Al Bratty, HA Alhazmi… - Drug discoveries & …, 2020 - jstage.jst.go.jp
The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently
affecting more than 200 countries and territories worldwide. It has been declared as …

Current targeted therapeutics against COVID-19: Based on first-line experience in China

Y Zhang, Q Xu, Z Sun, L Zhou - Pharmacological research, 2020 - Elsevier
SARS-CoV-2 is a novel strain, causing a global pandemic since the end of 2019. The
majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue …

Updated approaches against SARS-CoV-2

H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …

Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review

JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …

Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

[HTML][HTML] Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

KL Hon, KKY Leung, AK Leung, SY Qian… - Drugs in …, 2020 - ncbi.nlm.nih.gov
Many viral respiratory infections can cause severe acute respiratory symptoms leading to
mortality and morbidity. In the spring of 2003, the severe acute respiratory syndrome (SARS) …